Alvotech and Teva Pharmaceuticals announced the US Food and Drug Administration (FDA) has accepted for review a Biologics ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

The key to efficient pharma, manufacturing productionBy Anton Oosthiuizen, Commercial Director, QuickEasy SoftwareIssued by QuickEasy SoftwareJohannesburg, 18 Feb 2025Visit our press officeDon't let ...

For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...

Accurate monitoring of particle size and growth is essential to ensure scalability in the development of transfection vectors ...

ZymoChem, the biotech company creating sustainable materials for everyday products, announces the successful commercial-scale ...

The results were stunning. So too was the nationality of the company behind them. Akeso, a biotech firm, is Chinese.

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of ...

The Penn Center for Innovation has enabled world-changing advancements, from mRNA vaccines to CAR T cancer treatments.